参考文献/References:
[1] BENARD V B, GREEK A, JACKSON J E, et al. Overview of centers for disease control and prevention’s case investigation of cervical cancer study［J］. Journal of Women’s Health (2002),2019,28(7):890-896.
[2] SARMA U, BISWAS I, DAS A, et al. p16INK4a expression in cervical lesions correlates with histologic grading - a tertiary level medical facility based retrospective study[J]. Asian Pac J Cancer Prev，2017, 18(10):2643-2647.
[3] 徐书航 ,化定超 ,王新宇 .生物标志物在子宫颈癌筛查中的应用进展 [J].浙江医学 ,2019,41(8):854-858. XU Shuhang, HUA Dingchao, WANG Xinyu. Advances in the application of biomarkers in cervical cancer screening[J].Zhejiang Medical Journal, 2019,41(8):854-858.
[4] 马希 ,郝敏 .P16, Ki67及 FRα预测低度宫颈上皮内瘤变转归的研究进展 [J].现代肿瘤医学 ,2020,28(12):2168-2172. MA Xi, HAO Min. The research progress of the predictive effect of p16,Ki67 and FR α on the evolution of low grade cervical intraepithelial neoplasia [J]. Journal of Modern Oncology, 2020,28(12):2168-2172.
[5] ZHANG Xiaobo, SHEN Danhua. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion[J]. International Journal of Clinical and Experimental Pathology, 2018， 11(8):4109-4116.
[6] HERFS M, YAMAMOTO Y, LAURY A, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer［J］. Proceedings of the National Academy of Sciences of the United States of America,2012,109(26):10516-10521.
[7] 马新义 ,许励 ,王桂花 .P16和 Ki67在宫颈低级别鳞状上皮内病变中的表达及与预后的关系 [J].健康研究 ,2020,40(2):193-196. MA Xinyi, XU Li,WANG Guihua. Expression of P16 and Ki-67 in LSIL/CIN1and its relationship with prognosis [J].Health Research, 2020,40(2):193-196.
[8] 周静 , 李智 , 周玉 , 等 .宫颈癌组织中 Ep-CAM和 Ki67的表达及临床意义 [J].现代检验医学杂志 , 2019,34(6):24-27. ZHOU Jing,LI Zhi,ZHOU Yu,et al. Expression and clinicd value of Ep-CAM and Ki67 in the cervial carcinoma tissue[J]. Journal of Modern Laboratory Medicine,2019,34(6):24-27.
[9] SANGWAIYA A, GILL M, BAIRWA S,et al. Utility of P16/INK4a and Ki67 in preneoplasticand neoplastic lesions of cervix [J].Iranian Journal of Pathology, 2018,13(3):308-316.
[10] SARIAN L O, DERCHAIN S F, YOSHIDA A, et al. Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix[J].Gynecologic Oncology, 2006,102 (3):537-541.
[11] CALIL L N, EDELWEISS M I A, MEURER L ,et al. p16 INK4a and Ki67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection[J]. Pathology, Research and Practice,2014,210(8):482-487.
[12] YU Li, FEI Lingyan, LIU Xubin, et al. Application of P16/Ki67dual-staining cytology in cervical cancers [J]. Journal of Cancer,2019,10(12):2654-2660.
[13] WRIGHT T C,BEHRENS C M，RANGER-MOORE J, et al. Triaging HPV positive women with P16/ Ki67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial[J]. Gynecol Oncol,2017,144(1):51-56.
[14] AREáN-CUNS C, MERCADO-GUTIéRREZ M, PANIELLO-ALASTRUEY I, et al. Dual staining for P16/Ki67 is a more specific test than cytology for triage of HPV-positive women[J]. Virchows Archiv, 2018,473(5):599-606.
[15] 陈慎 ,杜明君 ,宋雅琴 .宫颈组织 HPV DNA与血清 Chemerin,Leptin水平联合检测对宫颈癌早期诊断的价值分析 [J].现代检验医学杂志 ,2019,34(3):42-46. CHEN Shen,DU Mingjun,SONG Yaqin.Value of combined detection of HPV DNA and serum levels of chemerin and leptin in early diagnosis of cervical cancer [J]. Journal of Modern Laboratory Medicine, 2019,34(3):42-46.
[16] WENTZENSEN N, SCHWARTZ L, ZUNA R E, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population [J]. Clinical Cancer Research,2012, 18(15):4154-62.
[17] ZIEMKE P, MARQUARDT K, GRIESSER H. Pre-dictive value of the combined p16 and Ki-67 immuno-cytochemistry in low-grade squamous intraepithelial lesions[J].Actacytologica,2014,58(5):489-494.
[18] KILLEEN J L, DYE T, GRACE C,et al. Improved abnormal Pap smear triage using cervical cancer biomarkers[J]. Journal of Lower Genital Tract Disease,2014,18(1):1-7.
[19] WANG Hairui, LI Yucong, GUO Huiqin,et al.A cocktail of P16INK4a and Ki67, P16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primarycervical cancer screening[J].Oncotarget,2017,8(48):83890-83899.
[20] GE Xuefei, ZHANG Ruiyi, YOU Ke, et al. Valuation of P16/Ki67 dual-stained cytology for detecting ervical precancerous disease[J].Chinese Journal of Family Planning,2017,25(12):855-859.
[21] 黄美虹 ,许荣海 ,洪巧莲 ,等 .P16/Ki67联合双染在宫颈病变筛查中的分流意义 [J].中国妇幼保健 ,2020,35(12):2174-2176. HUANG Meihong, XU Ronghai, HONG Qiaolian , et al. Shunt significance of p16/Ki67 double staining test in cervical lesions screening[J]. Maternal & Child Health Care of China, 2020,35(12):2174-2176..
[22] 贾漫漫 ,赵冬梅 ,郭珍 ,等 .P16/Ki67双染检测在高危型人乳头瘤病毒阳性人群中的分流效果评价 [J].中华预防医学杂志 ,2020,54(2):192-197. JIA Manman, ZHAO Dongmei, GUO Zhen, et al. Evaluation the triage performance of p16/Ki-67 dual staining for HR-HPV positive women [J]. Chinese Journal of Preventive Medicine, 2020,54(2):192-197.
[23] SARI A F, SAFAEI A, POURJABALI M, et al. Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions[J]. Iranian Journal of Medical Sciences, 2013, 38(1):15-21.
[24] BENEVOLO M , Mottolese M , Marandino F , et al. Immunohistochemical expression of p16<-sup>INK4a is predictive of HR-HPV infection in cervical low-grade lesions[J]. Modern Patholo-gy,2006,19(3):384-391.
[25] CHAROONWATANA T, BOONLIKIT S, YANARANOP M. Progression of precancerous cervical lesion predicted by P16 protein immunohistochemistry in rajavithi hospital[J]. Asian Pacific Journal of Cancer Prevention, 2019, 20(6):1809-1815.
[26] NEGRI G, VITTADELLO F, ROMANO F, et al. P16(INK4a) expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri[J]. Virchows Archiv, 2004, 445(6): 616-620.
[27] KRUSE A J, BAAK J P, JANSSEN E A,et al. Low-and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki67 immuno-quantitative variables[J].J Pathol,2003,199(4):462-470.
[28] 赖婷 ,朱燕 ,陈琳 ,等 .HPV E6IE7 mRNA，P16， Ki67在低级别宫颈鳞状上皮病变中的表达及意义 [J].癌症进展 ,2020,18(2): 168-171. LAI Ting, ZHU Yan, CHEN Lin, et al. Expression and significance of human papilloma virus E6/E7 mR-NA,p16 and Ki-67 in low-grade squamous intraepithe-lial lesion[J]. Oncology Progress, 2020,18(2):168-171.
[29] ALSHENAWY H A . Evaluation of P16, human papillomavirus capsid protein L1 and Ki67 in cervical intraepithelial lesions: Potential utility in diagnosis and prognosis [J]. Pathology - Research and Practice, 2014, 210(12):916-921.
[30] 邱晓阳 ,王少洪 ,郑璟 ,等 .免疫细胞化学 P16/Ki67双染检测对宫颈细胞学阴性且 HR-HPV阳性病例的分流作用及组织学 LSIL的转归预测价值 [J].中国癌症杂志 ,2020,30(7):512-518. QIU Xiaoyang,WANG Shaohong, ZHENG Jing, et al. Predictive value of immunocytochemical p16/Ki-67 double staining for cervical cytology negative and HR-HPV positive shunting and histological LSIL prognosis[J]. China Oncology , 2020,30(7):512-518.
[31] VRDOLJAK-MOZETI. D, KRA.EVI. M, VER.A OSTOJI. D, et al. HPV16 genotype, P16/Ki67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions [J].Cytopathology, 2015, 26(1):10-18..
[32] LIAO Guangdong,KANG Leni,LI Jing,et al. The effect of P16/Ki67 and P16/mcm2 on the detection of cervical intraepithelial neoplasia: a prospective study from China [J].International Journal of Clinical and Experimental Pathology, 2018,11(8):4101-4108.
[33] 周小会 , 王科芳 , 史艳丰 , 等 .免疫细胞化学 P16/ Ki67双染法在宫颈不典型鳞状上皮细胞及低级别鳞状上皮内病变中的应用价值 [J].中国妇幼保健 ,2019,34(21):5036-5038. ZHOU Xiaohui, WANG Kefang, SHI Yanfeng, et al. Application value of immunocytochemical P16/ Ki67 double staining in cervical atypical squamous epithelial cells and low-grade squamous intraepithelial lesions[J]. Maternal & Child Health Care of China , 2019,34(21):5036-5038.
[34] BERGERON C， IKENBERG H， SIDERI M，et al. Prospective evaluation of P16/Ki67 dual-stained cytology form managing women with abnormal Papanicolaou cytology: PALMS study results［J]. Cancer Cytopathol,2015,123(6):373-381.
[35] DAVEY D D, NARYSHKIN S,NIELSEN M L,et al. Atypical squamous cells of undetermined sig-nificance: inter laboratory comparisonand quality assurance monitors[J].Diagnostic Cytopatholo-gy,1994,11(4):390-396.
[36] ZHU Yuanhang, REN Chenchen, YANG Li, et al. Performance of p16/Ki67 immunostaining, HPV E6/ E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS [J]. BMC Cancer,2019,19（1): 271.
[37] WENTZENSEN N, CLARKE M A, BREMER R, et al. Clinical evaluation of human papilloma virus screening with P16/Ki67 dual stain triage in a large organized cervical cancer screening program[J].JAMA Intern Med,2019,179(7):0306．
[38] 许淑霞 , 林建松 , 詹燕美 . p16/Ki-67免疫细胞化学双染法对宫颈病变的筛查价值［ J].中华病理学杂志 , 2018, 47(3):207-208. XU Shuxia, LIN Jiansong, ZHAN Yanmei. Value of p16/Ki-67 dual-staining immunocytochemistry in cervical cancer screening[J]. Chinese Journal of Pathology, 2018, 47(3): 207-208.
[39] ZHANG Shaokai, JIA Manman, ZHAO Dongmei, et al. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China［J].Cancer Epidemiology, 2019, 59: 123-128．
[40] 马春华 , 马金 , 王琳 , 等 .P16/Ki67细胞学双染在宫颈癌筛查分流中的意义 [J].中国生育健康杂志 , 2020,31(4): 374-377.